• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2018.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Dermatology drug development co Foamix raises $64m
    July 30, 2019
    Mapi Pharma to launch generic Copaxone next year
    July 17, 2019
    Syqe begins marketing medical cannabis inhaler
    June 20, 2019
    SEEKING INCREASED US BACKING, ANCHIANO DELISTS FROM TASE
    June 18, 2019
    Intec Pharma Granted European Patent
    May 20, 2019
    Intec Pharma Announces Research Collaboration Agreement With Merck
    May 16, 2019
    For Medical Cannabis Users, the Biggest Problem Is a Consistent Dose, Says Sy
    May 7, 2019
    Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certifica
    April 11, 2019
    Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as
    March 26, 2019
    Copaxone rival Mapi Pharma to build Jerusalem plant
    March 19, 2019